STATINS IN ACUTE CORONARY SYNDROMES
This review article provides results of recent studies (ARMYDA, NAPLES II, MIRACL, ARMYDA-ACS, JUPITER, LUNAR) with the use of inhibitors of HMG CoA reductase (statins) in patients with acute coronary syndrome and patients undergoing percutaneous coronary intervention. Based on the results of these...
Main Authors: | A. L. Alyavi, S. R. Kenjaev, D. A. Alimov, M. L. Kenjaev, R. A. Rakhimova, A. K. Koyirov, M. S. Mirmaksudov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
InterMedservice
2019-03-01
|
Series: | Евразийский Кардиологический Журнал |
Subjects: | |
Online Access: | https://www.heartj.asia/jour/article/view/321 |
Similar Items
-
IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01) -
NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS
by: P. S. LAGUTA, et al.
Published: (2017-12-01) -
Prospective registry of percutaneous coronary interventions: Tyumen Cardiology Center’s experience
by: В. А. Кузнецов, et al.
Published: (2015-10-01) -
Coronary Arterial Stenting in Acute Coronary Syndrome
by: S. O. Sokolova, et al.
Published: (2006-02-01) -
ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS
by: S. T. Matskeplishvili, et al.
Published: (2013-08-01)